The published observations have shown that IRF4 controls experimental colitis in mice via T cell-derived IL-6 (31), and that IL-6 suppresses TGFβ-induced development of regulatory T cells and Foxp3 expression (4, 32). Here, TGFB1 is linked to colitis.